Galectin Therapeutics (GALT) Other Working Capital Changes (2010 - 2026)
Galectin Therapeutics (GALT) posted quarterly Other Working Capital Changes of -$1000.0 for Q4 2013, up 75.0% quarter-over-quarter from -$4000.0 in Q3 2013.
Powered by 
Analysis
Galectin Therapeutics (GALT) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Galectin Therapeutics' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$1000.0 for Q4 2013.
- In Q4 2013, Other Working Capital Changes changed N/A year-over-year to -$1000.0; the TTM figure through Dec 2013 stood at -$6000.0 (changed N/A YoY), while the FY2013 annual figure was -$6000.0, down 200.0% from the prior year.
- Other Working Capital Changes for Q4 2013 stood at -$1000.0, up from -$4000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $801000.0 in Q4 2023, with the low at -$467000.0 in Q3 2025.
- The 5-year median for Other Working Capital Changes is -$183000.0 (2023), against an average of -$28529.4.
- Peak annual rise in Other Working Capital Changes reached 25.0% in 2011, while the deepest fall reached 25.0% in 2011.
- Galectin Therapeutics' Other Working Capital Changes stood at -$2000.0 in 2010, then slumped by 50.0% to -$3000.0 in 2011, then soared by 66.67% to -$1000.0 in 2013.
- Business Quant data shows GALT's Other Working Capital Changes at -$1000.0 in Q4 2013, -$4000.0 in Q3 2013, and -$1000.0 in Q1 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Galectin Therapeutics | 304.34 Mn | 304.34 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -74,000.00 |
| Jun 30, 2026 | -74,000.00 |
| Mar 31, 2026 | -140,000.00 |
| Mar 31, 2026 | -140,000.00 |
| Dec 31, 2025 | 479,000.00 |
| Dec 31, 2025 | 479,000.00 |
| Sep 30, 2025 | -467,000.00 |
| Sep 30, 2025 | -467,000.00 |
| Jun 30, 2025 | -211,000.00 |
| Jun 30, 2025 | -211,000.00 |
| Mar 31, 2025 | -217,000.00 |
| Mar 31, 2025 | -217,000.00 |
| Dec 31, 2024 | 526,000.00 |
| Dec 31, 2024 | 526,000.00 |
| Sep 30, 2024 | -83,000.00 |
| Sep 30, 2024 | -83,000.00 |
| Jun 30, 2024 | -216,000.00 |
| Jun 30, 2024 | -216,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Mar 31, 2024 | -145,000.00 |